132 related articles for article (PubMed ID: 30274235)
21. Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation.
Sreenivasan Y; Sarkar A; Manna SK
Oncogene; 2003 Jul; 22(28):4356-69. PubMed ID: 12853972
[TBL] [Abstract][Full Text] [Related]
22. The effect of α-tocopherol and dithiothreitol in ameliorating emamectin benzoate cytotoxicity in human K562 cells involving the modulation of ROS accumulation and NF-κB signaling.
Luan S; Muhayimana S; Xu J; Zhang X; Xiao C; Huang Q
Ecotoxicol Environ Saf; 2019 Jan; 167():114-121. PubMed ID: 30315996
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin upregulates ferritin heavy chain in skeletal muscle cells.
Ikegami Y; Inukai K; Imai K; Sakamoto Y; Katagiri H; Kurihara S; Awata T; Katayama S
Diabetes; 2009 Jan; 58(1):61-70. PubMed ID: 18931039
[TBL] [Abstract][Full Text] [Related]
24. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation.
Kim DS; Park SS; Nam BH; Kim IH; Kim SY
Cancer Res; 2006 Nov; 66(22):10936-43. PubMed ID: 17108131
[TBL] [Abstract][Full Text] [Related]
25. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition.
Zhang KH; Tian HY; Gao X; Lei WW; Hu Y; Wang DM; Pan XC; Yu ML; Xu GJ; Zhao FK; Song JG
Cancer Res; 2009 Jul; 69(13):5340-8. PubMed ID: 19531652
[TBL] [Abstract][Full Text] [Related]
26. Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.
Kanzaki H; Mukhopadhya NK; Cui X; Ramanujan VK; Murali R
Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):1-11. PubMed ID: 26871511
[TBL] [Abstract][Full Text] [Related]
27. The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Wang H; Wang X; Li Y; Liao A; Fu B; Pan H; Liu Z; Yang W
Pharmazie; 2012 Feb; 67(2):187-92. PubMed ID: 22512091
[TBL] [Abstract][Full Text] [Related]
28. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.
Aversa I; Zolea F; Ieranò C; Bulotta S; Trotta AM; Faniello MC; De Marco C; Malanga D; Biamonte F; Viglietto G; Cuda G; Scala S; Costanzo F
J Exp Clin Cancer Res; 2017 Aug; 36(1):104. PubMed ID: 28774348
[TBL] [Abstract][Full Text] [Related]
30. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
Zou W; Ma X; Hua W; Chen B; Cai G
Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
[TBL] [Abstract][Full Text] [Related]
31. Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways.
Norouzi S; Norouzi M; Amini M; Amanzadeh A; Nabiuni M; Irian S; Salimi M
Daru; 2016 Jan; 24():1. PubMed ID: 26739353
[TBL] [Abstract][Full Text] [Related]
32. Pantoprazole Induces Mitochondrial Apoptosis and Attenuates NF-κB Signaling in Glioma Cells.
Geeviman K; Babu D; Prakash Babu P
Cell Mol Neurobiol; 2018 Nov; 38(8):1491-1504. PubMed ID: 30302629
[TBL] [Abstract][Full Text] [Related]
33. Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-κB.
Leung KC; Li MY; Leung BC; Hsin MK; Mok TS; Underwood MJ; Chen GG
Exp Cell Res; 2010 Dec; 316(20):3468-77. PubMed ID: 20647010
[TBL] [Abstract][Full Text] [Related]
34. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
35. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
[TBL] [Abstract][Full Text] [Related]
36. [Norcantharidin potentialize the chemosensitivity of adriamycin through the NF-κB/IκBα signaling pathway].
Song XN; Du HF; Yu LJ; Meng YF; Lü HY; Sun LX; Meng JB; Zhang JQ
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):809-13. PubMed ID: 22339951
[TBL] [Abstract][Full Text] [Related]
37. Sinapine reverses multi-drug resistance in MCF-7/dox cancer cells by downregulating FGFR4/FRS2α-ERK1/2 pathway-mediated NF-κB activation.
Guo Y; Ding Y; Zhang T; An H
Phytomedicine; 2016 Mar; 23(3):267-73. PubMed ID: 26969380
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
39. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation.
Campbell KJ; Witty JM; Rocha S; Perkins ND
Cancer Res; 2006 Jan; 66(2):929-35. PubMed ID: 16424027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
